Mereo BioPharma Group plc's website uses cookies. By continuing to browse you are agreeing to our use of cookies. Find out more about our Cookie Policy.
Link to article:
Dolgin, E. Antibody engineers seek optimal drug targeting TIGIT checkpoint. Nat Biotechnol 38, 1007–1009 (2020).